APO 020 (Omeprazole Delayed Release 20 mg)

Pill with imprint APO 020 is Pink / Red, Capsule-shape and has been identified as Omeprazole Delayed Release 20 mg. It is supplied by Apotex Corp.

Omeprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; duodenal ulcer; indigestion and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy. Omeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO 020

Omeprazole delayed release 20 mg APO 020

Omeprazole delayed release 20 mg APO 020 Front

Omeprazole delayed release 20 mg APO 020 Back

Omeprazole Delayed Release

Imprint: APO 020
Strength: 20 mg
Color: Pink / Red
Size: 18.00 mm
Shape: Capsule-shape
Availability: Rx and/or OTC
Drug Class: Proton pump inhibitors
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Apotex Corp.
Inactive Ingredients: magnesium hydroxide, mannitol, methacrylic acid - ethyl acrylate copolymer (1:1) type a, povidone k30, triethyl citrate, gelatin, ferric oxide red, titanium dioxide, ammonia, ferrosoferric oxide, alcohol, isopropyl alcohol, butyl alcohol, potassium hydroxide, propylene glycol, shellac
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
60505-0065	Apotex Corp.
00904-5684 (Discontinued)	Major Pharmaceuticals
60505-3952 (Discontinued)	Apotex Corp.
54569-5482	A-S Medication Solutions, LLC (repackager)
55289-0971 (Discontinued)	PDRX Pharmaceuticals Inc. (repackager)
33261-0087	Aidarex Pharmacuticals, LLC (repackager)
43063-0212 (Discontinued)	PDRX Pharmaceuticals Inc. (repackager)